METABOLIC ACTIVITY STUDY IN PEOPLE WITH DRUG ALLERGY USING «COCKTAIL» PHENOTYPING METHOD

METABOLIC ACTIVITY STUDY IN PEOPLE WITH DRUG ALLERGY USING «COCKTAIL» PHENOTYPING METHOD

Study of main CYP isoforms activity using «cocktail» method was conducted on patients suffered from drug allergy with different concurrent diseases in order to determine the presence of correlation between drug allergy appearance and changes in biotransformation activity.

Bibliographic Details
Main Authors:	E. A. Egorenkov, V. V. Smirnov, T. N. Myasnikova, T. S. Romanova
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	cytochrome p450 cyp «cocktail» method phenotyping drug allergy
Online Access:	https://www.pharmjournal.ru/jour/article/view/306

Similar Items

«COCKTAIL» METHODS OF CYTOCHROME P450 ISOFORMS ACTIVITY DETERMINATION <i>IN VIVO</i> USING BIOANALYTICAL METHODS: ACTUAL METHODS REVIEW AND OPPORTUNITIES OF THEIR APPLICATION IN CLINICAL PRACTICE
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

Aspects of «Cocktail» cytochrome P450 activity determination methods application with the view of drug treatment rationalization
by: E. . Egorenkov, et al.
Published: (2020-04-01)

Determination of the activity of drug-metabolizing enzymes - the prospects for their use in clinical practice
by: V. V. Smirnov, et al.
Published: (2018-02-01)

The Development and Validation of a Novel “Dual Cocktail” Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions
by: Mihwa Kwon, et al.
Published: (2020-09-01)

Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs
by: Léa Darnaud, et al.
Published: (2023-03-01)

DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ASSAY OF SUBSTRATES-MARKERS OF MAIN CYTOCHROME P450 ISOFORMS AND THEIR METABOLITES USING HPLC-MS/MS
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

CYP3A4 isoenzyme phenotyping for personalisation of pharmacotherapy
by: E. A. Egorenkov, et al.
Published: (2018-02-01)

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
by: Sychev DA, et al.
Published: (2018-05-01)

Effects of mulberry leaf extracts on activity and mRNA expression of five cytochrome P450 enzymes in rat
by: Chenming Sheng, et al.
Published: (2021-09-01)

Cytochrome P450 genes expression in human prostate cancer
by: Oksana Maksymchuk, et al.
Published: (2024-03-01)

Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review
by: Kenza Mansoor, et al.
Published: (2023-02-01)

Genetic variations in the drug metabolizing enzyme, CYP2E1, among various ethnic populations of Pakistan
by: Sagheer Ahmed, et al.
Published: (2020-08-01)

Electrochemical Activity of Cytochrome P450 1A2: The Relevance of O2 Control and the Natural Electron Donor
by: Dr. Célia M. Silveira, et al.
Published: (2021-02-01)

Measurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study
by: Constance A. Sobsey, et al.
Published: (2024-02-01)

Molecular Dynamics Simulations of a Cytochrome P450 from <i>Tepidiphilus thermophilus</i> (P450-TT) Reveal How Its Substrate-Binding Channel Opens
by: Abayomi S. Faponle, et al.
Published: (2021-06-01)

<i>Lysiphyllum strychnifolium</i> (Craib) A. Schmitz Extracts Moderate the Expression of Drug-Metabolizing Enzymes: In Vivo Study to Clinical Propose
by: Natthaporn Kuendee, et al.
Published: (2023-02-01)

Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility
by: Meng Li, et al.
Published: (2019-08-01)

In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin
by: Jan Thomann, et al.
Published: (2024-04-01)

Discovery of a cytochrome P450 enzyme catalyzing the formation of spirooxindole alkaloid scaffold
by: Tuan-Anh M. Nguyen, et al.
Published: (2023-02-01)

Editorial: Untapped metabolic diversity in legume-characteristic pathways
by: Mehran Dastmalchi, et al.
Published: (2023-01-01)

Global transcriptome modulation by xenobiotics: the role of alternative splicing in adaptive responses to chemical exposures
by: Andrew J. Annalora, et al.
Published: (2024-11-01)

INTRODUCTION OF AN N-GLYCOSYLATION SITE INTO UDP-GLUCURONOSYLTRANSFERASE 2B3 ALTERS ITS SENSITIVITY TO CYTOCHROME P450 3A1-DEPENDENT MODULATION
by: Tatsuro Nakamura, et al.
Published: (2016-11-01)

Isolation and characterization of the full-length cDNA encoding a member of a novel cytochrome p450 family (CYP320A1) from the tropical freshwater snail, Biomphalaria glabrata, intermediate host for Schistosoma mansoni
by: Anne E Lockyer, et al.
Published: (2005-05-01)

Cocktails : 101 cocktails to make and enjoy /
by: Effeny, Paul
Published: (2002)

Evaluation of Herb–Drug Interaction Between Danshen and Rivaroxaban in Rat and Human Liver Microsomes
by: Xu Wang, et al.
Published: (2022-07-01)

Corrigendum: Evaluation of herb–drug interaction between Danshen and rivaroxaban in rat and human liver microsomes
by: Xu Wang, et al.
Published: (2022-10-01)

Practice of CYP450 genotyping and phenotyping in children in a real-life setting
by: Frédérique Rodieux, et al.
Published: (2023-02-01)

Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population
by: Asif Jan, et al.
Published: (2023-08-01)

500 cocktails :
by: 353505 Sweetser, Wendy
Published: (c200)

The cocktail handbook /
by: 387590 Costantino, Maria
Published: (2001)

Analysis of CYP701A1 genes in gossypium species and functional characterization through gene silencing
by: Zhao Liang, et al.
Published: (2025-02-01)

Effect of eugenol on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activity in human liver microsomes
by: Naif Fahad M. Alharbi, et al.
Published: (2024-07-01)

Metformin represses drug – induced expression of CYP2B6 by the constitutive androstane receptor phosphorylation
Published: (2014-10-01)

CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population
by: Renata dos Santos Coura, et al.
Published: (2007-01-01)

Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs
by: Laxmi Manthalkar, et al.
Published: (2022-12-01)

Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk
by: Misheck Mudyiwa, et al.
Published: (2023-09-01)

A Computational Inter-Species Study on Safrole Phase I Metabolism-Dependent Bioactivation: A Mechanistic Insight into the Study of Possible Differences among Species
by: Lorenzo Pedroni, et al.
Published: (2023-01-01)

Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4
by: Ilia G. Denisov, et al.
Published: (2022-06-01)

Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
by: Florian Klomp, et al.
Published: (2020-12-01)

Mechanism of hepatoprotective action of methionine and composition “Metovitan” against a background of antituberculosis drugs administration to rats
by: S. I. Anisimova, et al.
Published: (2013-04-01)